Shanghai Composite Dips 0.29% Despite 1.61x Advance-Decline Ratio; BrightGene Soars 20%
The China Shanghai Composite Index fell by 0.29% today, contributing to a 1.02% decline over the past week and a 3.44% drop in the last month, highlighting ongoing market challenges. Despite this, the advance-decline ratio indicates positive sentiment, with more stocks advancing than declining across various market caps. Notable performers included BrightGene Bio-Medical Technology, which gained 20.01%, while Shandong Dongyue Silicone Material saw a 16.01% decline. The mixed performance suggests resilience in certain sectors, even as broader market pressures persist.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
